Comparison of vasodilatory properties between desflurane and propofol using perfusion index: a randomised controlled trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300069792

Enrollment

Unknown

Registered

2023-03-26

Start date

2022-11-07

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal cancer

Interventions

group D:desflurane

group P:propofol

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Participants scheduled for laparoscopic gastrointestinal surgerysurgery under general anaesthesia were eligible provided they were 18-65 yr old with an American Society of Anesthesiologists (ASA) physical status 1 or 2 and Body Mass Index 18-24 kg/m2;.

Exclusion criteria

Exclusion criteria: We excluded participants using the following criteria: severe hepatic and renal dysfunction; severe neurological or cardiovascular disease; allergic to general anesthetic drugs and patients with peripheral vascular disease or rheumatic disease.(e.g. diabetic vasculopathy or Raynauds disease);drugs that may affect sympathetic or parasympathetic tone (e.g. beta blockers or anticholinergics) and any neurological or psychiatric diseases, including history of, or treatment for, substance abuse,anxiety, or depression.

Design outcomes

Primary

Measure	Time frame
PI;	—

Secondary

Measure	Time frame
Hemodynamic index;	—

Countries

China

Contacts

Public ContactWei Li

Sun Yat-sen University Cancer Center

liw@sysucc.org.cn+86 13602855006

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026